These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Factors affecting antiretroviral drug adherence among HIV/AIDS adult patients attending HIV/AIDS clinic at Moi Teaching and Referral Hospital, Eldoret, Kenya. Talam NC, Gatongi P, Rotich J, Kimaiyo S. East Afr J Public Health; 2008 Aug; 5(2):74-8. PubMed ID: 19024414 [Abstract] [Full Text] [Related]
3. Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV. Zorrilla CD, Santiago LE, Knubson D, Liberatore K, Estronza G, Colón O, Acevedo M. Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1187-92. PubMed ID: 14983985 [Abstract] [Full Text] [Related]
4. One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients. Park WB, Choe PG, Kim SH, Jo JH, Bang JH, Kim HB, Kim NJ, Oh M, Choe KW. J Intern Med; 2007 Mar; 261(3):268-75. PubMed ID: 17305649 [Abstract] [Full Text] [Related]
6. Antiretroviral treatment adherence and its correlates in Addis Ababa, Ethiopia. Tadios Y, Davey G. Ethiop Med J; 2006 Jul; 44(3):237-44. PubMed ID: 17447389 [Abstract] [Full Text] [Related]
7. Factors associated with adherence to highly active antiretroviral therapy among children in two referral hospitals, northwest Ethiopia. Azmeraw D, Wasie B. Ethiop Med J; 2012 Apr; 50(2):115-24. PubMed ID: 22924280 [Abstract] [Full Text] [Related]
8. Awareness and attitude of health workers at a Nigerian HIV treatment clinic toward HIV/AIDS and HAART adherence. Olowookere SA, Fatiregun AA, Osagbemi KG. J Int Assoc Physicians AIDS Care (Chic); 2009 Apr; 8(3):208-12. PubMed ID: 19357425 [Abstract] [Full Text] [Related]
9. Compliance to antiretroviral therapy among AIDS patients in Aminu Kano Teaching Hospital, Kano, Nigeria. Iliyasu Z, Kabir M, Abubakar IS, Babashani M, Zubair ZA. Niger J Med; 2005 Apr; 14(3):290-4. PubMed ID: 16350700 [Abstract] [Full Text] [Related]
10. An adherence typology: coping, quality of life, and physical symptoms of people living with HIV/AIDS and their adherence to antiretroviral treatment. Bader A, Kremer H, Erlich-Trungenberger I, Rojas R, Lohmann M, Deobald O, Lochmann R, Altmeyer P, Brockmeyer N. Med Sci Monit; 2006 Dec; 12(12):CR493-500. PubMed ID: 17136004 [Abstract] [Full Text] [Related]
11. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study. Roux P, Carrieri MP, Villes V, Dellamonica P, Poizot-Martin I, Ravaux I, Spire B, MANIF2000 cohort study group. Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390 [Abstract] [Full Text] [Related]
12. Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data. Protopopescu C, Raffi F, Roux P, Reynes J, Dellamonica P, Spire B, Leport C, Carrieri MP, ANRS CO8 APROCO-COPILOTE Study Group. J Antimicrob Chemother; 2009 Sep; 64(3):599-606. PubMed ID: 19602563 [Abstract] [Full Text] [Related]
13. An exploration of factors influencing adherence to highly active anti-retroviral therapy (HAART) among people living with HIV/AIDS in Northern Thailand. Ruanjahn G, Roberts D, Monterosso L. AIDS Care; 2010 Dec; 22(12):1555-61. PubMed ID: 20582752 [Abstract] [Full Text] [Related]
14. Attitudes and practices towards HAART among people living with HIV/AIDS in a resource-limited setting in northern Burkina Faso. Guiro AK, Traore A, Somda A, Huang SL. Public Health; 2011 Nov; 125(11):784-90. PubMed ID: 22015209 [Abstract] [Full Text] [Related]
15. [Factors associated with adherence to therapy among HIV-infected patients in Bangui]. Mouala C, Kaba-Mebri J, Wata JB, Rey JL. Sante; 2006 Nov; 16(2):119-30. PubMed ID: 17116636 [Abstract] [Full Text] [Related]
16. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana. Vriesendorp R, Cohen A, Kristanto P, Vrijens B, Rakesh P, Anand B, Iwebor HU, Stiekema J. Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408 [Abstract] [Full Text] [Related]
17. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment. Roux P, Carrieri MP, Cohen J, Ravaux I, Poizot-Martin I, Dellamonica P, Spire B. Clin Infect Dis; 2009 Nov 01; 49(9):1433-40. PubMed ID: 19807275 [Abstract] [Full Text] [Related]
18. Successive switching of antiretroviral therapy is associated with high psychological and physical burden. Sherr L, Lampe F, Norwood S, Leake-Date H, Fisher M, Edwards S, Arthur G, Anderson J, Zetler S, Johnson M, Harding R. Int J STD AIDS; 2007 Oct 01; 18(10):700-4. PubMed ID: 17945049 [Abstract] [Full Text] [Related]
19. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease. Schönnesson LN, Williams ML, Ross MW, Diamond PM, Keel B. Int J STD AIDS; 2007 Jun 01; 18(6):369-73. PubMed ID: 17609023 [Abstract] [Full Text] [Related]